Authors

Rabi Upadhyay, MD, an instructor in the Department of Medicine at NYU Langone Health's Perlmutter Cancer Center

Latest:

Fellows on Film: What Makes a Good Mentor for an Oncology Fellow?

Michael L. Grossbard, MD, and Rabi Upadhyay, MD, Instructor, Department of Medicine at NYU Grossman School of Medicine, discuss the qualities that make someone a great mentor for an oncology fellow.

Yair Lotan, MD

Latest:

Dr Lotan on the Benefits and Complications Associated With Radical Cystectomy in BCG-Unresponsive NMIBC

Yair Lotan, MD, discusses the benefits and complications associated with radical cystectomy for patients with BCG-unresponsive NMIBC.

Charlotte Rivers, MD

Latest:

Dr Rivers on Unmet Needs in Patients With Head and Neck Cancer

Charlotte Rivers, MD, discusses unmet needs in head and neck cancer and highlights the advantages of radiation therapy over surgery for this patient population.

Daniel E. Haggstrom, MD

Latest:

Dr Haggstrom on Future Research Directions in EGFR+ and ALK+ NSCLC

Daniel E. Haggstrom, MD, discusses future research directions within EGFR-and ALK-mutant non–small cell lung cancer.

Cesar A. Santa-Maria, MD

Latest:

Dr. Santa-Maria on Trastuzumab Deruxtecan in HER2-low TNBC

Cesar A. Santa-Maria, MD, discusses exploratory data seen with trastuzumab deruxtecan in patients with triple-negative breast cancer.

Nadia Harbeck, MD, PhD

Latest:

Dr. Harbeck on the Background of the WSG ADAPT-TP Trial in HR+, HER2+ Breast Cancer

Nadia Harbeck, MD, PhD, discusses the background of the phase 2 WSG ADAPT-TP trial in hormone receptor-positive, HER2-positive early-stage breast cancer.

Rachel Giles, MD, PhD

Latest:

Dr Giles on the Importance of Shared Decision Making When Managing GU Cancers

Rachel Giles, MD, PhD, discusses the importance of incorporating shared decision making in the treatment of patients with genitourinary cancers.

Jasmine M. Zain, MD

Latest:

Dr. Jasmine Zain: Challenges in T-Cell Lymphoma Treatment

Jasmine Zain, MD, director of the T-cell Lymphoma Program, professor of hematology and hematopoietic stem cell transplantation, of City of Hope National Medical Center, discusses the challenges of treatment for patients with T-cell lymphoma.

Robert DeBernardo, MD

Latest:

Dr DeBernardo on an Ovarian Cancer Patient Case Study

Robert DeBernardo, MD, discusses a case study seen in a patient with ovarian cancer.

Alaa Muslimani, MD

Latest:

Dr Muslimani on Unanswered Questions to be Addressed in HER2+ mCRC

Alaa Muslimani, MD, discusses unanswered questions in the treatment of patients with metastatic colorectal cancer, highlighting how these unmet needs may be addressed through continued research.

Moh’d Khushman, MD

Latest:

Dr. Khushman on Best Practices in the Management of GI Cancers

Moh’d Khushman, MD, discusses best practices in the management of gastrointestinal cancers.

Charlotte Schubert, PhD

Lydia Mills

Latest:

Palliative Care Can Address Gaps in Oncology Landscape

Palliative medicine has evolved to become a standard for high-quality cancer care, helping patients relieve suffering throughout their journey, improving quality of life, and prolonging survivorship.

Victoria Johnson

Latest:

FDA Panel Gives Beti-Cel Unanimous Support of Benefit in β-thalassemia

The FDA’s Cellular, Tissue, and Gene Therapies Advisory Committee voted unanimously in favor of the benefit of betibeglogene autotemcel for the treatment of transfusion-dependent β-thalassemia in adult and pediatric patients with a non–β0/β0 genotype.

Kevin Hakimi

Latest:

Kevin Hakimi on the Rationale of the PADRES Trial in RCC

Kevin Hakimi, discusses the rationale for the phase 2 PADRES trial in clear cell renal cell carcinoma.

Margot O’Neill, PA-C, MHS

Latest:

Unmet Needs and Future Perspectives in Colorectal Cancer

The panel concludes with perspectives on the future of treatment for patients with colorectal cancer, including unmet needs in the disease space.

Benjamin V. Stone, MD

Latest:

Dr Stone on the Investigation of Limited English Proficiency and PSA Screening Rates in Prostate Cancer

Benjamin V. Stone, MD, discusses clinical implications derived from a retrospective study on the effect of limited English proficiency on prostate-specific antigen screening rates in American men with prostate cancer, as well as the need to improve equitable access to PSA screening across academic and community centers.

Maria I. Carlo, MD

Latest:

Non–Clear Cell RCC: Clinical Rationale Behind Therapy

A brief review of the clinical rationale behind therapeutic regimens used for patients with non-clear cell carcinoma.

Sandip P. Patel, MD, University of California San Diego

Latest:

Perioperative Approaches to NSCLC

Drs Chaitali Nangia and Sandip P. Patel debate between best treatment approaches for patients with non–small cell lung cancer in the perioperative setting.

Triparna Sen, PhD

Latest:

Insights from ARTEMIS-001

Panelists discuss how preliminary results from the pPhase 3 ARTEMIS-001 study indicate that iIfinatamab dDeruxtecan, a B7-H3 antibody-drug conjugate, demonstrates promising antitumor activity in relapsed small cell lung cancer, with a notable partial response rate and manageable safety profile among treated patients.